ER, 70, has taken pantoprazole 40 mg daily for 5 years, started for heartburn during a stressful period. She has no Barrett esophagus, bleeding history or ongoing NSAID use and has been symptom-free. What does the Canadian deprescribing guideline suggest?
For adults who have completed at least 4 weeks of PPI therapy for mild to moderate reflux or esophagitis and are symptom-free, the deprescribing guideline recommends decreasing to a lower dose or stopping and using the PPI on demand. Patients with Barrett esophagus, severe esophagitis or a history of bleeding ulcers are excluded. Rebound symptoms can be managed with antacids or H2 blockers as needed. Source: Farrell B et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline (Can Fam Physician 2017;63:354).
Continuing long-term PPIs without reassessing the indication.
Practice more PEBC MCQ GI, Renal & Hepatic Disorders questions
Exam-style questions with worked answers, then full timed mocks. Free to start.
Build a daily practice habit — a few exam-style questions a day, with worked answers. Free to start.
Start practicing →Original practice material written to the public PEBC blueprint; not a past or real exam question. Not affiliated with or endorsed by The Pharmacy Examining Board of Canada (PEBC). Educational practice material for exam preparation only. Not medical advice and not a substitute for current product monographs, clinical guidelines or professional judgement. Questions have not yet been reviewed by a licensed pharmacist.